期刊文献+

综合性ICU铜绿假单胞菌医院内感染临床及药敏分析

The clinical and drug sensitivity analysis of Pseudomonas aeruginosa in ICU
暂未订购
导出
摘要 目的探讨综合性ICU铜绿假单胞菌(PA)引发的医院内感染临床及其药敏特点.方法对温州医学院附属第一医院ICU 1997~2002年铜绿假单胞菌医院感染进行回顾性分析.用16种常用抗生素进行体外药敏试验,采用Kirby-Bauer纸片扩散法按NCCLS标准进行.结果根据感染部位,PA引发的感染常见于下呼吸道(87.64%)、尿路(7.87%)及皮肤(4.49%).患者基础疾患包括神经系统疾病(43.82%),COPD(12.36%),各种恶性肿瘤(8.99%),以及各种创伤和大手术后等.体外药物敏感率从高到低依次为头孢哌酮-舒巴坦(84.85%),头孢他啶(80%),妥布霉素(78.46%),庆大霉素(67.5%),亚胺培南(56.72%),奈替米星(55.74%),培氟沙星(45.33%),替卡西林(38.60%),其它头孢3代的敏感率均较低.结论综合性ICU内PA引起的机会感染率高,在临床上应在药敏指导下用药,经验性治疗则优先考虑选用头孢哌酮-舒巴坦、头孢他啶、氨基糖甙类和亚胺培南等敏感性较高的抗生素,同时注意防止是交叉感染,积极治疗原发病. Objective To investigate the clinical and drug sensitivity analysis of Pseudomonas aeruginosa (PA) in IUC. Drug sensitivity tests were made for 16 antimicrobial agents and conducted by K-B paper method according to the standard made by NCCLS. Methods A retrospective investigation was made for PA of nosocomial infection from January 1997 to March 2002 in ICU of our hosptal. Results The mainly infection position was respitatory (87.64%),the next were urinary (7.87%) and skin (4.49%). The underlying diseases of the patients included nerve system disease (43. 82%), chronic obstructive pulmonary disease (12. 36%), malignant tumor (8.99 % ), injurity and after operations. Drug sensitivity rate of Cefoperazone-Sulbactam was 84. 85 %, Ceftazidime 80% ,Tobramycin 78.46% ,Gentamycin 67.5% ,Imipenem 56.72% ,Netilmcin 55.74% ,Pefloxacin 45.33% ,Ticarcillin 38.60%. The drug sensitivity rate of the other third generation cephalosporius were low. Conclusions The infection rate of PA in ICU was high. Antimicrobial treatment with PA infection shoud be guided by drug sensitivity test. While the first choice for experimental treatment is Cefoperazone-Sulbactam,Ceftazidime,Aminoglycoside or Imipenem. At the same time,we must avoid across infection and treat the primary diseases activly.
出处 《中国微生态学杂志》 CAS CSCD 2005年第5期372-373,共2页 Chinese Journal of Microecology
关键词 铜绿假单胞菌 抗生素 敏感性 医院感染 Psudomonas aeruginosa Antimicrobial agents Drug sensitivity Nosocomial infection
  • 相关文献

参考文献5

二级参考文献15

  • 1Bergogne-Berezin E. Guideline on antimicrobial chemotherapy for prevention and treatment of infections in the ICU. J Chemother, 2001,1: 134-149.
  • 2Goossens H. MYSTIC program: summary of European data from 1997 to 2000. Diagn Microbiol Infect Dis, 2001, 41: 183-189.
  • 3Leblebicioglu H, Gunaydin M, Esen S, et al. Surveillance of antimicrobial resistance in gram-negative isolates from ICU in Turkey:analysis of data from the last 5 years. J Chemother, 2002, 14:140-146.
  • 4Karlowsky JA, Kelly LJ, Thornsberry C , et al. Susceptibility to fluoroquinolones among commonly isolated Gram-negative bacilli in 2000:TRUST and TSN data for the United States. J Autimicrob Agents , 2002,19: 21-31.
  • 5National Committee for Clinical Laboratory Standards. 2002. Performance standards for antimicrobial susceptibility testing. Approved standard M100-S12. National Committee for Clinical Laboratory Standards,Wayne, Pa.2002,1.
  • 6Chanawong A. M' Zali FH, Heritage J, et al. Three cefotaximases,CTX-M-9, CTX-M-13, CTX-M-14, among Enterobacteriaceae in the People's Republic of China. Antimicrob Agents Chemother, 2002, 46:630-637.
  • 7申正义,孙自镛,王洪波.武汉地区临床分离菌耐药性监测[J].中华内科杂志,1998,37(7):440-443. 被引量:42
  • 8府伟灵,朱桂森,徐咏涛,严卫民.重庆地区1325株细菌的分离鉴定及其耐药性调查[J].中华医院感染学杂志,1999,9(3):184-186. 被引量:57
  • 9吕媛,刘健,康子胜,李家泰.北京地区临床分离961株致病菌对常用抗菌药物体外抗菌活性研究[J].中国临床药理学杂志,1999,15(3):161-170. 被引量:14
  • 10钱宏法,杨仁洪,陶岳多,吕卫兵.铜绿假单胞菌698株对14种抗生素耐药分析[J].南京医科大学学报(自然科学版),2000,20(1):67-68. 被引量:16

共引文献1094

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部